Published in Gene Therapy Weekly, February 17th, 1997
Suming Wang and Jean-Michel Vos from the University of North Carolina have developed an infectious miniviral vector based on Epstein-Barr virus (EBV) and herpes simplex virus type 1 (HSV-1) which shows potential for use as a cancer and inherited gene therapy vector ("A Hybrid Herpesvirus Infectious Vector Based on Epstein-Barr Virus and Herpes Simplex Virus Type 1 for Gene Transfer into Human Cells In Vitro and In Vivo," Journal of Virology, December 1996;70(12):8422-30).
"In this study, we present a novel EBV/HSV-based miniviral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.